With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.
CGD Policy Blogs
- (-) Remove Peter Baker filter Peter Baker
- (-) Remove Y-Ling Chi filter Y-Ling Chi
- (-) Remove Coronavirus Preparedness & Response filter Coronavirus Preparedness & Response
- (-) Remove June 2020 filter June 2020
June 29, 2020